Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|January 22, 2013
Recent advances in prostate development and links to prostatic diseasesGinny L Powers, Paul C MarkerPlos One|March 29, 2017
Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancerBao Le, Ginny L Powers, Yu Tong Tam, et al.Molecular Cancer Research : MCR|August 24, 2014
Phosphodiesterase 4D inhibitors limit prostate cancer growth potentialGinny L Powers, Kimberly D P Hammer, Maribella Domenech, et al.The Prostate|March 21, 2014
A novel method for somatic transgenesis of the mouse prostate using the Sleeping Beauty transposon systemKimberly D P Hammer, James D Alsop, Rita A Buresh-Stiemke, et al.Differentiation; Research in Biological Diversity|August 30, 2008
Does prostate cancer co-opt the developmental program?Paul C MarkerDifferentiation; Research in Biological Diversity|February 21, 2007
Fibroblast growth factor receptor signaling through MEK-ERK is required for prostate bud inductionSheri L Kuslak, Paul C MarkerDifferentiation; Research in Biological Diversity|August 19, 2006
Branching morphogenesis in the prostate gland and seminal vesiclesAxel A Thomson, Paul C MarkerDevelopmental Dynamics : an Official Publication of the American Association of Anatomists|April 1, 2003
Spontaneous mutation in mice provides new insight into the genetic mechanisms that pattern the seminal vesicles and prostate glandPaul C Marker, Rajvir Dahiya, Gerald R CunhaPlos One|December 17, 2013
The proteasome inhibitor bortezomib induces an inhibitory chromatin environment at a distal enhancer of the estrogen receptor-α geneGinny L Powers, Prashant Rajbhandari, Natalia M Solodin, et al.Development (Cambridge, England)|January 5, 2007
The mouse seminal vesicle shape mutation is allelic with Fgfr2Sheri L Kuslak, Joshua L Thielen, Paul C MarkerPageof 5